PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Avatrombopag - Thrombocytopenia

PAD Profile : Avatrombopag - Thrombocytopenia

Keywords :
NICE, low platelet level, bone marrow, thrombopenia, spleen, chronic liver disease, CLD
Brand Names Include :
Doptelet

Traffic Light Status

Status 1 of 1.

Status :
Red
Formulations :
  • Not Specified
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

No drugs returned.

Other Indications

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
07 October 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Area Prescribing Committee recommends avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure in line with NICE guidance (NICE TA 626)

Avatrombopag is a payment by results excluded medicine and will be considered RED on the traffic light system. Prescribers will be required to complete a blueteq form at initiation

Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient's medication

Associated BNF Codes

09. Nutrition and Blood
09.01.04. Drugs used in platelet disorders
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More